The press conference, attended by US President Donald J. Trump and a number of technology leaders, revealed the revolutionary potential of artificial intelligence in the medical field. Ellison introduced that the system can use AI to diagnose the early stage of cancer through a simple blood test. The AI can generate personalized mRNA vaccines based on the genomic data of the cancer cells and the DNA of the patients within 48 hours. This breakthrough technology not only accelerates the formulation of treatment plans but also provides precise medical services for cancer patients.
This cancer vaccine program is part of the larger “Stargate” project. “Stargate” is a thorough AI infrastructure plan promoted by the current U.S. government with a total investment of up to $500 billion, jointly initiated by Oracle, OpenAI, and SoftBank Group. The initial investment of the project is $100 billion, and it is planned to expand to $500 billion in the next four years. The goal of the project is to build 10 large data centers across the United States, each covering an area of 500,000 square feet, and may be further expanded to 20 facilities. The first data center of the project will be located in Abilene, Texas.
Ellison also mentioned at the press conference that the potential of artificial intelligence in the medical field is not limited to cancer vaccines. By combining electronic health records (EHR), AI systems will provide doctors in remote areas with the opportunity to access treatment options at major cancer centers, greatly narrowing the inequality of medical resources. This series of plans not only demonstrates the determination of technology giants to promote medical innovation, but also marks a major progress in the integration of artificial intelligence and the medical industry.
As the use of artificial intelligence in healthcare continues to expand, especially with its integration into electronic health records, we can expect technology to play a greater role in improving the quality of cancer care. This new system heralds a new era of personalized cancer treatment, and perhaps in the near future, we can see more patients receiving effective treatment options in a shorter period of time, truly achieving the goal of precision medicine. From early diagnosis of cancer to personalized treatment to resource sharing, AI-driven solutions are reshaping the future of the global medical system.
